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Abstract
Objective:  To  evaluate  the  dose--response  relationship  between  smoking  load  and  cardiopul-
monary fitness,  as  measured  with  cardiopulmonary  exercise  testing  (CPET),  in  adult  smokers
free of  respiratory  diseases.
Methods:  After  a  complete  clinical  evaluation  and  spirometry,  95  adult  smokers  (35  men  and
60 women)  underwent  CPET  on  a  treadmill.
Results:  The  physiological  responses  during  CPET  showed  lower  cardiorespiratory  fitness  levels,
regardless of  smoking  load,  with  a  peak  V ′O2 lower  than  100%  of  the  expected  value  and  a
lower maximum  heart  rate.  We  observed  a  significant  moderate  negative  correlation  between
smoking load  and  peak  V ′O2 .  The  smoking  load  also  presented  a  significant  negative  correlation
with maximum  heart  rate(r  =  −0.36;  p  <  0.05),  lactate  threshold(r  =  −0.45;  p  <  0.05),  and  peak
ventilation(r =  −0.43;  p  <  0.05).  However,  a  dose--response  relationship  between  smoking  load
quartiles and  cardiopulmonary  fitness  was  not  found  comparing  quartiles  of  smoking  loads  after
adjustment  for  age,  sex  and  cardiovascular  risk.
Conclusion:  There  appears  to  be  no  dose--response  relationship  between  SL  and  cardiopul-
monary fitness  in  adult  smokers  with  preserved  pulmonary  function,  after  adjusting  the  analysis
for age  and  cardiovascular  risk.  Our  results  suggest  that  smoking  cessation  might  be  useful  as
the primary  strategy  to  prevent  cardiopulmonary  fitness  decline  in  smokers,  regardless  of  smok-
ing load.  Thus,  even  a  very  low  dose  of  tobacco  use  must  be  avoided  in  preventive  strategies
focusing on  becoming  people  more  physically  active  and  fit.sa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
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obacco  use  continues  to  be  the  leading  global  cause  of
reventable  deaths.1 Smoking  affects  health  among  young
mokers  without  established  chronic  disease.2 Smoking
ncreases  the  risk  of  developing  respiratory  and  cardiovas-
ular  diseases,  and  it  is  responsible  for  causing  many  types
f  cancer,  even  in  non-smokers  exposed  to  second-hand
obacco  smoke  (SHS).  When  smoking,  a  person  inhales  an
verage  of  2500  toxic  substances  leading  to  symptoms  such
s  increased  mucus  production,  airway  inflammation,  infec-
ions,  and  decreased  muscular  function.3
Smoking  is  associated  not  only  with  lower  physical  activ-
ty,  but  also  with  impaired  cardiorespiratory  fitness  and
eart  rate  variability.4 The  best  way  to  determine  cardiore-
piratory  fitness  is  through  cardiopulmonary  exercise  testing
CPET).  One  of  the  variables  used  to  determine  the  func-
ional  cardiorespiratory  capacity  is  the  measurement  of  the
ulmonary  oxygen  uptake  (V ′O2 )  at  peak  exercise  intensity.
Smoking  load  (SL),  expressed  in  pack-years,  is  widely
sed  as  a  simple  way  to  quantify  current  tobacco  use.
n  SL  greater  than  15  pack-years  should  have  detailed
creening  for  respiratory  diseases,  such  as  chronic  obstruc-
ive  pulmonary  disease  (COPD).5 Lung  cancer  screening  is
ecommended  for  individuals  with  an  SL  greater  than  30
ack-years.6 However,  the  health  effects  of  lower  SL  are
ot  fully  understood.  Although  there  is  detailed  knowledge
f  the  negative  effects  of  smoking,  there  are  few  studies
n  the  dose--response  relationship  of  SL  and  cardiorespi-
atory  fitness.  The  objective  of  this  study  was  to  evaluate
he  dose--response  relationship  between  SL  and  cardiopul-
onary  fitness  through  CEPT  in  adult  smokers  with  preserved
ulmonary  function.
ethods
n  this  cross-sectional  study,  95  adult  smokers  (35  men
nd  60  women)  underwent  CPET  on  a  treadmill,  after  a
omplete  clinical  evaluation  and  spirometry.  Participants
ere  selected  from  the  EPIMOV  Study  (Epidemiology  and
uman  Movement  Study).  Briefly,  the  EPIMOV  Study,  is  a
ohort  study  with  the  main  objective  of  investigating  the
ongitudinal  association  between  sedentary  behavior  and
hysical  inactivity  with  the  occurrence  of  hypokinetic  dis-
ases,  especially  cardiorespiratory  diseases.  The  volunteers
ere  recruited  through  dissemination  in  social  networks,
olders  displayed  in  the  universities  of  the  region,  local
agazines  and  newspapers.  Inclusion  criteria  for  this  study
ere  male  or  female  aged  between  18  and  90  years  and
eing  free  from  self-reported  physician-diagnosed  cardiac
r  pulmonary  disease.  Exclusion  criteria  were  orthopedic
roblems,  recent  respiratory  infections,  unstable  or  stable
ngina  in  the  last  four  weeks,  recent  myocardial  infarction,
ngioplasty  or  cardiac  surgery  in  the  last  three  months  and
pirometric  abnormalities.  We  have  excluded  participants
onsidering  impaired  functional  vital  capacity  (FVC  <  80%
redicted)  and/or  low  relationship  between  forced  expira-
ory  volume  in  the  1st  second  and  FCV  (FEV1/FVC  ratio  ≤  0.7
n  absolute  value).7--9 In  order  to  calculate  the  predicted
pirometric  variables,  Brazilian  reference  values10 were
sed.  The  participants  were  informed  about  the  possible
a
d
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isks  and  discomforts  of  the  procedures  proposed  in  the
resent  study  and  signed  a  consent  form.  The  Ethics  Commit-
ee  for  Research  in  Humans  of  the  local  university  approved
his  study  by  the  186.796  protocol.
linical  evaluation
he  height  and  weight  of  the  subjects  were  measured  and
he  body  mass  index  (BMI)  was  calculated.  Personal  and
emographic  data  were  collected  (e.g.,  sex,  age,  educa-
ion,  home  address).  In  addition,  participants  answered  the
hysical  activity  readiness  questionnaire  (PAR-Q)  in  order  to
valuate  some  possible  contraindication  for  CPET11;  ques-
ions  about  respiratory  disorders  based  on  the  American
horacic  Society  (ATS)  questionnaire12 to  investigate  pol-
utants  exposition,  history  of  asthma  and  smoking  status;
nd  cardiovascular  disease  (CVD)  risk  stratification  was
erformed  according  to  the  American  College  of  Sports
edicine  (ACSM).13 We  investigated  the  presence  of  self-
eported  major  risk  factors  for  CVD,  including  age  (male  ≥  45
ears;  female  ≥  55  years);  family  history  of  premature  coro-
ary  heart  disease  (CHD)  (definite  myocardial  infarction
efore  55  years  old  in  father  or  65  years  old  in  mother  or
ther  first-degree  relative);  systemic  arterial  hypertension;
iabetes;  dyslipidemia  and  current  cigarette  smoking.
pirometry
he  forced  vital  capacity  (FVC)  was  determined  using  a  cal-
brated  spirometer  (Quark  PTF;  COSMED,  Pavonadi  Albano,
taly),  following  the  criteria  of  the  American  Thoracic  Soci-
ty  (ATS).14 The  forced  expiratory  volume  in  1-s  (FEV1)  was
easured,  and  then  the  FEV1/FVC  ratio  was  calculated.
ll  spirometric  values  were  measured  in  absolute  and  per-
entage  of  normal  values  by  using  reference  values  for  the
razilian  population.10
ardiopulmonary  exercise  testing
ll  participants  were  informed  about  the  preparatory  pro-
edures  prior  to  CPET.  Several  recommendations  were
tandardized,  such  as  not  smoking  on  the  assessment  day,
ot  performing  intense  exercise  on  test  day  and  avoiding
offee,  tea  or  on  test  day.  CPET  was  done  on  a  treadmill
ATL,  Inbrasport,  Curitiba,  Brasil)  by  using  a  ramp  proto-
ol.  Pulmonary  oxygen  uptake  (V ′O2 ),  carbon  dioxide  output
V ′CO2 )  and  minute  ventilation  (VE)  were  recorded  using  a
omputerized  system  for  cardiopulmonary  exercise  testing,
eriodically  calibrated  following  the  manufacturer’s  recom-
endations  (Quark  PTF;  COSMED,  Pavona  di  Albano,  Italy).
eart  rate  was  monitored  during  CPET  with  a  12-lead  EKG
C12x;  COSMED,  Pavona  di  Albano,  Italy).  The  V ′O2 equiva-
ent  to  the  lactate  threshold  was  obtained  through  a  gas
xchange  technique,  visually  inspecting  the  VCO2/V
′
O2
slope
nflection  point  (v-slope)  and  by  using  the  oxygen  (VE/V ′O2 )
nd  carbon  dioxide  (VE/V ′CO2 ) ventilatory  equivalents.
15 The
ata  were  averaged  every  15-s.  The  average  of  the  last
5  s  at  the  end  of  the  test,  immediately  before  the  recov-
ry  phase,  was  considered  the  peak  V ′O2 .  Subjects  with  less
81
Table  1  General  characteristics  of  the  study  subjects  and
physiological  responses  observed  in  the  cardiopulmonary
exercise  testing.
Mean  ±  SD
Age  (years) 45  ±  12
Weight (kg)  83  ±  23
Sex (Male/Female)  35/60
Height  (m)  1.63  ±  0.98
BMI (Kg/m2)  30.7  ±  7.5
FVC (L)  3.32  ±  3.03
FVC (%  of  predicted)  90.5  ±  13.8
FEV1 (L) 2.68  ±  0.91
FEV1 (%  of  predicted) 88.7  ±  15.3
FEV1/FVC  (%)  80.0  ±  7.4
Peak VO2 (ml/min)  2038  ±  774
Peak VO2 (ml/min/Kg)  24  ±  8
Peak VO2 (%  of  expected)  88  ±  15
Anaerobic  threshold  (ml/min)  1376  ±  505
Anaerobic  threshold  (%  of  the
predicted  peak  VO2)
60  ±  12
Rate of  gas  exchange  (VCO2/VO2)  1.13  ±  0.11
Maximum  heart  rate  (bpm)  153  ±  19
Maximum  heart  rate  (%  of  predicted)  88  ±  8
Maximum  minute  ventilation(L/min)  66  ±  25
SD, standard deviation; BMI, body mass index; FVC, forced vital
capacity; FEV1, forced expiratory volume in the first second;
o
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Figure  1  Significant  correlations  (p  <  0.05)  between  smokingCardiovascular  fitness  and  smoking  load  
than  83%  of  the  predicted  peak  V ′O2 were  considered  exercise
intolerant.16
Statistical  analysis
The  sample  size  was  calculated  assuming  a  minimum  clini-
cally  significant  difference  of  442  mL/min  in  peak  VO2 during
the  CPET  in  healthy  individuals  (i.e.,  the  lower  limit  of
normal).17 This  was  selected  because  the  standard  deviation
of  peak  V ′O2 in  healthy  adults  is  about  400  mL/min.
17 From
this,  the  probability  of  alpha  and  beta  errors  was  set  at  0.05
and  0.20,  respectively,  establishing  a  minimum  sample  size
of  17  participants  in  each  of  the  quartiles  for  CPET  to  detect
a  442  mL  difference  in  peak  V ′O2 .  Thus,  a  sample  size  of  68
subjects  was  calculated  in  our  study.
Data  were  analyzed  and  normal  variables  presented  as
the  mean  ±  standard  deviation,  or  as  median  (interquartile
range)  for  non-normal  variables.  The  correlation  between
SL  and  the  data  obtained  in  the  CPET  were  evaluated  with
the  Pearson  or  Spearman  correlation  coefficient,  according
to  the  normality  of  the  variables.  The  SL  was  retrospectively
categorized  into  the  25th,  50th,  and  75th  percentiles.  Peak
V ′O2 was  compared  using  multivariate  analysis  of  variance
(MANOVA)  and  adjusted  for  the  following  main  confounding
variables:  age,  sex,  systemic  arterial  hypertension,  diabetes
mellitus,  dyslipidemia,  obesity,  and  physical  inactivity.  A  p
value  <0.05  was  considered  significant.
Results
This  study  evaluated  95  smokers  without  pulmonary  dis-
ease.  The  subjects  were,  on  average,  middle-aged,  with
a  BMI  indicating  obesity  and  normal  spirometry  (Table  1).
Restrictive  impairment  was  present  in  13  (13.7%)  subjects.
Cardiovascular  risk  factors  were  present:  13%  were  diabetic,
21%  had  systemic  arterial  hypertension,  28%  had  dyslipide-
mia,  46%  were  obese,  and  69%  were  physically  inactive.
In  general,  the  physiological  responses  during  the  CPET
represented  a  lower  cardiorespiratory  fitness  level,  as  indi-
cated  by  peak  V ′O2 lower  than  100%  of  the  expected  and  a
lower  maximum  heart  rate  (Table  1).  Thirty-two  subjects
(33.6%)  had  exercise  intolerance.  A  significant  moderate
negative  correlation  between  SL  and  the  peak  V ′O2 was
detected  (Fig.  1).  The  SL  also  showed  significant  correla-
tion  with  maximum  heart  rate  (r  =  −0.36;  p  <  0.05),  lactate
threshold  (r  =  −0.45;  p  <  0.05)  and  peak  VE  (r  =  −0.43;
p  <  0.05).
The  SL  quartiles  were  divided  as  ≤3,  between  3  and  12,
between  12.1  and  32  and  >32  pack-years.  The  participants
with  an  SL  greater  than  32  pack-years  were  older  and  had
a  higher  prevalence  of  dyslipidemia  and  physical  inactivity
(Table  2).
Despite  the  negative  correlation  between  the  SL  and  the
peak  V ′O2 ,  the  peak  V
′
O2
values  were  not  statistically  different
among  the  SL  quartiles  (Fig.  2)  when  adjusted  for  age,  sex
and  risk  factors  for  cardiovascular  disease.Discussion
In  this  study,  we  evaluated  the  influence  of  the  SL  on  car-
diopulmonary  fitness  in  asymptomatic  adult  smokers  and
l
e
(
(VO2, oxygen uptake; VCO2, carbon.
bserved  negative  correlations  between  these  variables.
espite  these  negative  correlations,  no  dose--response  rela-oad and  peak  oxygen  uptake  at  the  end  of  cardiopulmonary
xercise  testing  in  women  (r  =  −0.26;  R2 =  0.06)  and  men
r =  −0.36;  R2 =  0.12).  Overall,  the  correlation  was  moderate
r =  −0.32;  R2 =  0.10).
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Table  2  Demographic,  anthropometric,  and  cardiovascular  risk  data  in  the  study  subjects,  stratified  according  to  the  smoking
load quartiles.
Smoking  load  (pack-years)
Quartile  1 Quartile  2  Quartile  3  Quartile  4
≤3 3--12 12.1--32 >32
Age  (years)  40  ±  11  40  ±  12  48  ±  9  57  ±  9*,**,***
Sex  (Male/Female)  8/16  12/13  10/14  5/17
Weight (Kg)  88.7  ±  20.7  86.1  ±  24.4  85.1  ±  25.7  70.6  ±  18.3
Height (m) 1.65  ±  0.99 1.65  ±  0.91  1.64  ±  0.10  1.59  ±  0.97
BMI (Kg/m2) 32.6  ±  7.6 31.2  ±  7.5 31.3  ±  8.4 27.5  ±  6
Arterial hypertension 25%  20%  20.8%  18.2%
Diabetes mellitus 12.5%  4%  8.3%  31.8%
Dyslipidemia 8.3%  20%  41.7%  45.5%*
Obesity  54.2%  40%  33.3%  40.9%
Physical inactivity 70.8%  52%  66.7%  90.0%**
BMI, body mass index.
* p < 0.05 vs. Quartile 1.
** p < 0.05 vs. Quartile 2.
*** p < 0.05 vs. Quartile 3.
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Figure  2  Peak  oxygen  uptake  at  the  end  of  cardiopulmonary
exercise  testing  according  to  smoking  load  in  pack-yr  (quartile
1, ≤3;  quartile  2,  3--12;  quartile  3,  12.1--32;  and  quartile  4,
>32). There  were  no  significant  differences  among  groups  after
multivariate  analysis  of  variance  adjusted  by  age,  sex,  arte-
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with  an  SL  of  3  pack-years  and  subjects  with  an  SL  of  moreial hypertension,  diabetes,  dyslipidemia,  obesity,  and  physical
nactivity.
We  have  also  observed  that  the  cardiopulmonary  fitness
s  determined  by  the  peak  V ′O2 was  12%  lower  than  the
xpected  in  all  four  of  the  SL  quartiles  we  studied,  and
bout  one-third  (33.6%)  of  the  subjects  were  exercise  intol-
rant.  In  fact,  our  results  reinforce  the  current  literature.
isigoj-Durakovic  et  al.18 evaluated  350  Croatian  Armed
orces  members,  of  which  175  were  smokers  and  175  were
on-smokers.  The  smokers  were  classified  into  three  groups
ccording  to  their  SL  (group  1,  from  1  to  5  pack-years;  group
,  from  5  to  10;  and  group  3,  over  10  pack-years),  and  the
t
von-smokers  in  three  control  groups.  Cardiopulmonary  fit-
ess  by  treadmill  CPET  showed  a significant  reduction  in
he  peak  V ′O2 ,  even  in  smokers  with  an  SL  lower  than  five
ack-years.  As  far  as  we  know,  very  few  studies  have  evalu-
ted  the  negative  effects  of  very  low  SL.  As  with  the  Croatian
tudy,  our  results  show  that  smoking  has  a  negative  effect
n  cardiopulmonary  fitness  in  a  non-dose  dependent  man-
er.  The  effect  persisted  at  very  low  SLs  even  though  the
′
O2
was  dose  dependent  and  peaked,  at  an  SL  above  three
ack-years.
We  showed  that  greater  reductions  in  cardiopulmonary
tness  in  smokers  with  a higher  SL  are  associated  with  age,
yslipidemia,  and  physical  inactivity.  According  to  Malta
t  al.,19 the  frequency  of  intense  smoking  has  a  tendency  to
ncrease  with  age,  increasing  more  than  two  fold  between
8--24  and  55--64  years.  Likewise,  the  cardiopulmonary  and
uscular  fitness  decreases  as  the  individual  ages.18 Smoking
s  also  related  to  other  cardiovascular  risk  factors.  Studies
ave  shown  that  heavy  smokers  present  more  comorbidities
n  comparison  to  light  smokers.20 Heavy  smokers  have  lower
alues  in  diffusing  capacity,  which  explains  the  reduction
n  maximum  exercise  capacity.21 Nevertheless,  it  is  possi-
le  that  observational  associations  between  heavy  smoking
nd  cardiovascular  risks  can  be  misinterpreted,  since  heavy
moking  is  related  to  sedentary  behavior,  clinical  conditions
nd  socioeconomic  factors  that  cannot  be  entirely  elimi-
ated  as  potential  confounders.22 Furlanetto  et  al.23 studied
he  level  of  physical  activity  in  the  daily  life  of  116  subjects,
mokers  and  non-smokers,  using  a  pedometer.  The  results
ave  shown  a  significant  reduction  in  the  daily  physical  activ-
ty  levels  in  adult  smokers  despite  the  absence  of  obstructive
ulmonary  disease.  However,  comparing  the  SL  quartiles  in
ur  study,  we  found  no  difference  in  the  negative  effects  of
moking  in  cardiopulmonary  fitness  on  comparing  subjectshan  32  pack-years.
The  SL  did  have  a  negative  correlation  with  the  main
ariables  of  the  cardiopulmonary  fitness  in  the  CPET.  The
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maximum  heart  rate  showed  very  low  average  values  (88%
of  the  expected)  despite  the  fact  that  the  values  for  respira-
tory  exchange  ratio  were  compatible  with  maximum  effort.
A  lower  maximum  heart  rate  in  smokers  during  CPET  was
also  observed  by  Unverdorben  et  al.24 Smoking  alters  the
chronotropic  response  to  exercise,  increasing  the  risk  of
developing  coronary  artery  disease  and  death.25 This  dele-
terious  effect  on  chronotropic  response  to  exercise  can  lead
to  compromised  cardiac  output,  to  a  reduction  in  transcu-
taneous  oxygen  tension,  to  a  reduction  in  the  anaerobic
threshold,  and  to  an  increase  in  catecholaminerelease.26
In  fact,  a  significant  reduction  in  the  peak  V ′O2 was  even
observed  in  SHS.25
Despite  a  reduction  by  12%  in  the  expected  peak  V ′O2 , the
subjects  of  this  study  presented  a  normal  anaerobic  thresh-
old  (about  60%  of  the  expected  peak  V ′O2 ).  In  contrast  to  our
results,  Glaser  et  al.27 observed  a  significant  reduction  in  the
anaerobic  threshold  in  smokers  compared  to  non-smokers.
However,  physical  inactivity  affects  the  values  of  V ′O2 and
the  anaerobic  threshold,  a  confounder,  which  was  not  con-
sidered.  It  is  well  known  that  smokers  present  higher  VE/V ′CO2
ratios  and  a  lower  anaerobic  threshold.27 This  shows  a  reduc-
tion  in  ventilatory  efficiency  and  certainly  contributes  to  the
overall  reduction  in  the  exercise  capacity  at  higher  but  not
at  lower  exercise  intensity.
Some  limitations  of  our  study  must  be  considered.
Despite  the  correlations  observed  in  the  study,  the  cross-
sectional  design  did  not  allow  us  to  establish  any  relationship
of  cause  and  effect.  We  did  not  evaluate  a  control  group
of  non-smokers,  which  might  have  changed  the  interpreta-
tion  of  the  data.  However,  the  predicted  V ′O2 values  show
that  exercise  capacity  was  clearly  below  normal.  The  con-
venient  selection  and  the  low  sample  size  may  have  led  us
into  an  external  validity  issue  regarding  the  SL  sub-groups,
and  could  explain  the  higher  prevalence  of  comorbidities
than  in  the  general  population.  The  lack  of  an  objective  con-
trol  over  the  last  cigarette  smoked  before  CPET  is  another
limitation  of  the  present  study.  Smoking  can  cause  acute
effects  in  physiological  responses  to  the  CPET.  However,
all  the  CPETs  were  performed  in  the  same  cardiovascular
clinic  and  the  clinic  stuff  carefully  advised  our  participants
about  avoiding  exercise  and  smoking  before  the  CPET.  For
this  reason,  we  are  confident  we  have  been  able  to  mini-
mize  this  bias.  Additionally,  we  did  not  evaluate  the  level
of  nicotine  dependence.  We  recognize  that  this  could  be  of
great  value  since  there  are  very  few  studies  on  the  corre-
lation  of  nicotine  dependence  and  cardiopulmonary  fitness.
We  should  also  state  that  the  self-reported  evaluations  are
subjective.
Conclusion
Based  on  our  findings,  after  adjusting  the  analysis  for
age  and  cardiovascular  risk,  there  appears  to  be  no
dose--response  relationship  between  SL  and  cardiopul-
monary  fitness  in  adult  smokers  with  preserved  pulmonary
function.  Therefore,  smoking  cessation  might  be  useful  as
the  primary  strategy  to  prevent  cardiopulmonary  fitness
decline  in  smokers,  regardless  of  smoking  load.  Thus,  even  a
very  low  dose  of  tobacco  use  must  be  avoided  in  preventive
strategies.83
thical disclosures
rotection  of  human  and  animal  subjects.  The  authors
eclare  that  the  procedures  followed  were  in  accordance
ith  the  regulations  of  the  relevant  clinical  research  ethics
ommittee  and  with  those  of  the  Code  of  Ethics  of  the  World
edical  Association  (Declaration  of  Helsinki).
onfidentiality  of  data.  The  authors  declare  that  they  have
ollowed  the  protocols  of  their  work  center  on  the  publica-
ion  of  patient  data.
ight  to  privacy  and  informed  consent.  The  authors  have
btained  the  written  informed  consent  of  the  patients  or
ubjects  mentioned  in  the  article.  The  corresponding  author
s  in  possession  of  this  document.
onflict of interest
he  authors  have  no  conflicts  of  interest  to  declare.
unding
his  study  received  financial  support  in  the  form  of  a
esearch  grant  from  the  São  Paulo  Research  Foundation
FAPESP),  in  the  State  of  São  Paulo,  Brazil,  grant  no.
011/07282-6.
eferences
1. Organization WH. WHO report on the global tobacco epidemic,
2011: warning about the dangers of tobacco. Geneva: World
Health Organization; 2011.
2. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C,
Thomas O, Robinson J, et al. Cigarette smoking is associated
with dose-related and potentially reversible impairment of
endothelium-dependent dilation in healthy young adults. Cir-
culation. 1993;88 Pt 1:2149--55 [Epub 1993/11/01].
3. Zanoni CT, Rodrigues CMC, Mariano D, Suzan A, Boaventura
LC, Galvão F. Efeitos do treinamento muscular inspiratório em
universitártios tagabistas e não tabagistas. Inspiratory muscle
training effects in smokers and nonsmokers univertitary stu-
dents. Fisioter Pesqui. 2012;19:147--52.
4. Lee CL, Chang WD. The effects of cigarette smoking on aerobic
and anaerobic capacity and heart rate variability among female
university students. Int J Womens Health. 2013;5:667--79 [Epub
2013/11/10].
5. Pereira CAC, Neder JA. Diretrizes para testes de func¸ão pul-
monar. J Bras Pneumol. 2002;28 Suppl. 3:S1--238.
6. Lowry KP, Gazelle GS, Gilmore ME, Johanson C, Munshi V, Choi
SE, et al. Personalizing annual lung cancer screening for patients
with chronic obstructive pulmonary disease: a decision analysis.
Cancer. 2015;121:1556--62 [Epub 2015/02/06].
7. Eriksson B, Lindberg A, Mullerova H, Ronmark E, Lundback
B. Association of heart diseases with COPD and restrictive
lung function -- results from a population survey. Respir Med.
2013;107:98--106 [Epub 2012/11/07].
8. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive
lung disease and markers of inflammation: data from the
Third National Health and Nutrition Examination. Am J Med.
2003;114:758--62 [Epub 2003/06/28].
9. Mannino DM, Holguin F, Pavlin BI, Ferdinands JM. Risk fac-
tors for prevalence of and mortality related to restriction on
81
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
24  
spirometry: findings from the First National Health and Nutri-
tion Examination Survey and follow-up. Int J Tuberc Lung Dis.
2005;9:613--21 [Epub 2005/06/24].
0. Pereira CA, Sato T, Rodrigues SC. New reference values for
forced spirometry in white adults in Brazil. J Bras Pneumol.
2007;33:397--406 [Epub 2007/11/06].
1. Thomas S, Reading J, Shephard RJ. Revision of the physi-
cal activity readiness questionnaire (PAR-Q). Can J Sport Sci.
1992;17:338--45 [Epub 1992/12/01].
2. Ferris BG. Epidemiology standardization project (American Tho-
racic Society). Am Rev Respir Dis. 1978;118 Pt 2:1--120 [Epub
1978/12/01].
3. Thompson PD, Arena R, Riebe D, Pescatello LS. ACSM’s
new preparticipation health screening recommendations from
ACSM’s guidelines for exercise testing and prescription,
ninth edition. Curr Sports Med Rep. 2013;12:215--7 [Epub
2013/07/16].
4. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R,
Coates A, et al. Standardisation of spirometry. Eur Respir J.
2005;26:319--38 [Epub 2005/08/02].
5. Wasserman K, Hansen J, Sue DY, Whipp BJ, Casaburi R. Princi-
ples of exercise testing and interpretation. 4th ed. Philadelphia:
Lippincott Wiliams & Wilkins; 2005, 576 p.
6. Neder JA, Nery LE, Shinzato GT, Andrade MS, Peres C, Silva AC.
Reference values for concentric knee isokinetic strength and
power in nonathletic men and women from 20 to 80 years old.
J Orthop Sports Phys Ther. 1999;29:116--26.
7. Neder JA, Nery LE, Castelo A, Andreoni S, Lerario MC, Sachs A,
et al. Prediction of metabolic and cardiopulmonary responses
to maximum cycle ergometry: a randomised study. Eur Respir J.
1999;14:1304--13 [Epub 2000/01/07].
8. Misigoj-Durakovic M, Bok D, Soric M, Dizdar D, Durakovic Z, Jukic
I. The effect of cigarette smoking history on muscular and car-
diorespiratory endurance. J Addict Dis. 2012;31:389--96 [Epub
2012/12/19].
9. Malta DC, Moura EC, Silva SA, Oliveira PPVd, Silva VLdCe.
Prevalência do tabagismo em adultos residentes nas capitaisV.T.  Lauria  et  al.
dos estados e no Distrito Federal, Brasil, 2008. J Bras Pneumol.
2010;36:75--83.
0. Asvold BO, Bjorngaard JH, Carslake D, Gabrielsen ME, Skorpen
F, Smith GD, et al. Causal associations of tobacco smoking with
cardiovascular risk factors: a Mendelian randomization analysis
of the HUNT Study in Norway. Int J Epidemiol. 2014;43:1458--70
[Epub 2014/05/29].
1. Tzani P, Aiello M, Colella M, Verduri A, Marangio E, Olivieri
D, et al. Lung diffusion capacity can predict maximal exer-
cise in apparently healthy heavy smokers. J Sports Sci Med.
2008;7:229.
2. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J.
Active smoking and the risk of type 2 diabetes: a sys-
tematic review and meta-analysis. JAMA. 2007;298:2654--64
[Epub 2007/12/13].
3. Furlanetto KC, Mantoani LC, Bisca G, Morita AA, Zabatiero J,
Proenca M, et al. Reduction of physical activity in daily life
and its determinants in smokers without airflow obstruction.
Respirology. 2014;19:369--75 [Epub 2014/02/04].
4. Unverdorben M, van der Bijl A, Potgieter L, Venter C, Munjal
S, Qiwei L, et al. Effects of different levels of cigarette smoke
exposure on prognostic heart rate and rate -- pressure-product
parameters. J Cardiovasc Pharmacol Ther. 2008;13:175--82
[Epub 2008/07/17].
5. de Borba AT, Jost RT, Gass R, Nedel FB, Cardoso DM, Pohl HH,
et al. The influence of active and passive smoking on the cardio-
respiratory fitness of adults. Multidiscip Respir Med. 2014;9:34
[Epub 2014/07/11].
6. Unverdorben M, der Bijl A, Potgieter L, Liang Q, Meyer BH,
Roethig HJ. Effects of levels of cigarette smoke exposure on
symptom-limited spiroergometry. Prev Cardiol. 2007;10:83--91
[Epub 2007/03/31].
7. Glaser S, Koch B, Ittermann T, Schaper C, Dorr M, Felix SB, et al.
Influence of age, sex, body size, smoking, and beta blockade
on key gas exchange exercise parameters in an adult popu-
lation. Eur J Cardiovasc Prev Rehabil. 2010;17:469--76 [Epub
2010/03/23].
